Current Genomics in Cardiovascular Medicine

Author(s): Vinit Sawhney, Scott Brouilette, Dominic Abrams, Richard Schilling, Benjamin O'Brien

Journal Name: Current Genomics

Volume 13 , Issue 6 , 2012

Become EABM
Become Reviewer
Call for Editor


Cardiovascular disease (CVD) is a heterogeneous, complex trait that has a major impact on human morbidity and mortality. Common genetic variation may predispose to common forms of CVD in the community, and rare genetic conditions provide unique pathogenetic insights into these diseases. With the advent of the Human Genome Project and the genomic era, new tools and methodologies have revolutionised the field of genetic research in cardiovascular medicine. In this review, we describe the rationale for the current emphasis on large-scale genomic studies, elaborate on genome wide association studies and summarise the impact of genomics on clinical cardiovascular medicine and how this may eventually lead to new therapeutics and personalised medicine.

Keywords: Cardiovascular disease, GWAS, Gene sequencing, Personalised medicine, Pharmacogenetics, lysosomal lipase acid A gene, morbidity, mortality, pregenome, alleles

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 07 August, 2012
Page: [446 - 462]
Pages: 17
DOI: 10.2174/138920212802510484
Price: $65

Article Metrics

PDF: 4